Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 12-09-2016 | Practice Area: | Corporate and M&A |
| Deal Title: | GlaxoSmithKline Divestment of Non-Core Assets to Aspen | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Slaughter and May advised GlaxoSmithKline plc on a series of agreements with the Aspen Group as part of GSK's strategy of simplification through focusing on core therapeutic areas. GSK was to divest its anaesthesia portfolio to Aspen for GBP180 million plus milestones of up to GBP100 million.
|
||
| Financial Center: | London | Value: | 100.01-500.00 |
| Advised Party: | Vendor | Law Firm | Slaughter and May |
| Target Company Jurisdiction: | United Kingdom | Acquiror Jurisdiction: | United Kingdom |
| Classification: |
Strategic Buyer Acquisitions Private Company |
Lawyer | Richard Jones |
